---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-020481"
form_type: "8-K"
ticker: "RTGN"
cik: "0001836295"
company_name: "RetinalGenix Technologies Inc."
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:40:51.940983+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# RetinalGenix appoints Vinay Mehindru, MD, MBA to board of directors

## Summary
- Vinay Mehindru, age 55, appointed director effective July 25, 2022.
- He has over 25 years of healthcare experience; currently CEO of Exemplary Health.
- Previously President of AdventHealth's clinically integrated networks (2014-2019) and CMO.
- No family relationships or material interests with company directors or officers.
- Appointment fills board seat; no departure of existing directors.

## SEC filing metadata
- accession: 0001493152-22-020481
- form_type: 8-K
- ticker: RTGN
- cik: 0001836295
- company_name: RetinalGenix Technologies Inc.
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1836295/000149315222020481/0001493152-22-020481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1836295/000149315222020481/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-020481
- JSON: https://secwatch.observer/filing/0001493152-22-020481.json
- Plain text: https://secwatch.observer/filing/0001493152-22-020481.txt

## Key facts
- Executive change
  Vinay Mehindru was appointed as director at RetinalGenix Technologies Inc..
  - Action: appointed
  - Role: director
  source text: On July 25, 2022, the Board of Directors (the “Board”) of RetinalGenix Inc. (the ‘Company”) appointed Vinay Mehindru, MD, MBA to serve as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1836295/000149315222020481/0001493152-22-020481-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.